- Home
- NERV vs MRM Comparison
NERV vs MRM Comparison
Compare NERV & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- MRM
- Stock Information
- Founded
- NERV 2007
- MRM 2000
- Country
- NERV United States
- MRM Japan
- Employees
- NERV N/A
- MRM N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- MRM Other Consumer Services
- Sector
- NERV Health Care
- MRM Consumer Discretionary
- Exchange
- NERV Nasdaq
- MRM Nasdaq
- Market Cap
- NERV 14.6M
- MRM 16.0M
- IPO Year
- NERV 2014
- MRM 2020
- Fundamental
- Price
- NERV $4.78
- MRM $2.55
- Analyst Decision
- NERV Hold
- MRM
- Analyst Count
- NERV 1
- MRM 0
- Target Price
- NERV $5.00
- MRM N/A
- AVG Volume (30 Days)
- NERV 9.3M
- MRM 2.1M
- Earning Date
- NERV 11-05-2025
- MRM 05-22-2026
- Dividend Yield
- NERV N/A
- MRM N/A
- EPS Growth
- NERV N/A
- MRM N/A
- EPS
- NERV 1.48
- MRM 0.04
- Revenue
- NERV N/A
- MRM $55,915,220.00
- Revenue This Year
- NERV N/A
- MRM N/A
- Revenue Next Year
- NERV N/A
- MRM N/A
- P/E Ratio
- NERV $3.06
- MRM $62.61
- Revenue Growth
- NERV N/A
- MRM 12.79
- 52 Week Low
- NERV $1.15
- MRM $0.34
- 52 Week High
- NERV $12.46
- MRM $4.45
- Technical
- Relative Strength Index (RSI)
- NERV 63.84
- MRM 58.86
- Support Level
- NERV $4.27
- MRM $2.37
- Resistance Level
- NERV $12.46
- MRM $2.73
- Average True Range (ATR)
- NERV 0.86
- MRM 0.18
- MACD
- NERV 0.16
- MRM 0.02
- Stochastic Oscillator
- NERV 24.84
- MRM 64.71
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.